Pharma Asset Strategy I - Epi and Disease Burden
This chapter concentrates on key metrics in evaluating disease epidemiology, with absolute vs relative risk, as well as discusses disease burden involved in indication analyses.
Course curriculum
-
-
Epidemiology and Disease Burden - Full Lecture
-
Supplemental Materials
-
Case Example - Multiple Sclerosis
-
Free Preview - Lecture Snippet (Epi and Disease Burden)
FREE PREVIEW
-
About this course
- $99.00
- 4 lessons
- 0.5 hours of video content